4//SEC Filing
RIGGS RANDALL B 4
Accession 0000882796-06-000057
CIK 0000882796other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 4:59 PM ET
Size
6.0 KB
Accession
0000882796-06-000057
Insider Transaction Report
Form 4
RIGGS RANDALL B
Senior VP Business Development
Transactions
- Award
Stock Options (Right to buy)
2006-06-22$13.44/sh+70,000$940,800→ 70,000 totalExercise: $13.44From: 2007-06-22Exp: 2016-06-22→ Common Stock (70,000 underlying)
Footnotes (2)
- [F1]Of the 70,000 stock options granted to Mr. Riggs, 12,647 are incentive stock options and 57,353 are non-qualified stock options.
- [F2]Options become exercisable at the rate of 25% after 1 year and then 1/48 per month thereafter until fully vested and exercisable after 48 months.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001226229
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 4:59 PM ET
- Size
- 6.0 KB